John Sperzel III

Chembio’s dengue field test earns Brazilian nod

By GREGORY ZELLER // Add another critical Brazilian regulatory approval to Chembio Diagnostics’ portfolio. The Medford-based point-of-care diagnostics specialist announced this its week the Agência Nacional de Vigilância Sanitária, Brazil’s…



Can Chembio rebound? You bet your assays

By GREGORY ZELLER // Chembio Diagnostics Systems Inc. has significantly diversified its product portfolio, built up its global sales infrastructure and expanded its operational capacities – but the numbers just…


At Chembio, looking beyond the numbers

By GREGORY ZELLER // While it made “important advances … intended to prepare the company for growth,” according to its CEO, Chembio Diagnostic Systems has suffered another subpar fiscal quarter….


In Brazil, a big forward step for Chembio

The national health-regulatory agency of Brazil has approved commercial use of Chembio Diagnostics’ rapid field rest for the Zika virus – a major step toward selling the product in the…


Sales drop, tax bite sting Chembio Diagnostics

Medford biotech Chembio Diagnostic Systems Inc. took it on the chin in the second quarter, with steep losses attributed to declining sales for its infectious-disease detectors and a one-time, multimillion-dollar…